MedPath
Found 1 clinical trials|View Analysis
Sort by:

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382

Phase 2
Recruiting
Conditions
Human Immuno-deficiency Virus (HIV) Disease
Interventions
Drug: Placebo for Budigalimab
Drug: Budigalimab
Drug: Placebo for ABBV-382
Drug: ABBV-382
First Posted Date
2023-09-13
Last Posted Date
2024-12-20
Lead Sponsor
AbbVie
Target Recruit Count
140
Registration Number
NCT06032546
Locations
🇵🇷

Clinical Research Puerto Rico /ID# 256956, San Juan, Puerto Rico

🇵🇷

HOPE Clinical Research /ID# 257487, San Juan, Puerto Rico

🇿🇦

Wits RHI Research Centre /ID# 257354, Johannesburg, Gauteng, South Africa

and more 77 locations
© Copyright 2025. All Rights Reserved by MedPath